ESTRO 2024 - Abstract Book

S2272

Clinical - Upper GI

ESTRO 2024

Keywords: OAR robustness, esophageal cancer, NTCP prediction

References:

1. Visser S, O. Ribeiro C, Dieters M, et al. Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach. Radiotherapy and Oncology. 2022;177:197-204. doi:10.1016/j.radonc.2022.11.001 2. Jin JY, Hu C, Xiao Y, et al. Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Nonesmall Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617). Int J Radiat Oncol Biol Phys. 2017;99:S151-S152.

2848

Digital Poster

Stereotactic body radiotherapy in elderly pancreatic cancer patients: single-institution experience

Elena Onorati 1 , Michele Fiore 1,2 , Gian Marco Petrianni 2 , Gabriele D'Ercole 1 , Pasquale Trecca 2 , Barnaba Floreno 2 , Claudia Tacconi 1 , Martina Benincasa 1 , Salvatore Minuti 1 , Edy Ippolito 1,2 , Sara Ramella 1,2